Biden NIH Pick Under Scrutiny for Funding From Pfizer

Biden NIH Pick Under Scrutiny for Funding From Pfizer
From left to right: National Cancer Institute Director Dr. Monica Bertagnolli, first lady Jill Biden (C), and Rep. Jackie Speier (D-Calif.) at the University of California, San Francisco Helen Diller Comprehensive Care Center in San Francisco, Calif., on Oct. 7, 2022. John G. Mabanglo/Pool/Getty Images
Zachary Stieber
Updated:
0:00
President Joe Biden’s choice to head the U.S. National Institutes of Health has hauled in hundreds of millions of dollars from the pharmaceutical giant Pfizer in recent years, raising concerns about whether she'd serve the public independently.

Dr. Monica Bertagnolli received $247 million in research funding from Pfizer from 2016 to 2021, according to disclosures filed Open Payments, a government-run program that collects and publishes data on payments from drug companies to doctors and others.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics